This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignees: Korea Advanced Institute of Science and Technology, Yonsei University. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2025
Title: Hyun Yong Koh: Innovator in Epilepsy Research
Introduction
Hyun Yong Koh is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of epilepsy research, particularly through his innovative patent that addresses ganglioglioma and related diseases. His work has implications for diagnosing and treating epilepsy, showcasing his commitment to advancing medical science.
Latest Patents
Hyun Yong Koh holds a patent for a "Ganglioglioma-induced animal model and a method for diagnosing and treating ganglioglioma and related diseases." This invention relates to a biomarker of epilepsy and includes a composition for diagnosing epilepsy, an epilepsy-induced animal, and a composition for preventing or treating epilepsy. Specifically, it involves a composition for diagnosing epilepsy that comprises a BRAF mutant protein and a nucleic acid molecule, along with an agent capable of detecting the protein or nucleic acid molecule. The patent also describes an epilepsy-induced animal transformed with the BRAF mutant nucleic acid molecule and a composition for the prevention or treatment of epilepsy that includes a BRAF mutant protein activity inhibitor. This patent highlights his innovative approach to tackling complex medical challenges.
Career Highlights
Throughout his career, Hyun Yong Koh has worked with esteemed institutions such as the Korea Advanced Institute of Science and Technology and Yonsei University. His experience in these prestigious organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Hyun Yong Koh has collaborated with notable colleagues, including Jeong Ho Lee and Dong Seok Kim. These partnerships have further enriched his research and have led to advancements in understanding and treating epilepsy.
Conclusion
Hyun Yong Koh's contributions to epilepsy research through his innovative patent demonstrate his dedication to improving medical outcomes for patients. His work continues to inspire advancements in the field and highlights the importance of innovation in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile